Technical Analysis for TRML - Tourmaline Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 15.68 | -2.00% | -0.32 |
TRML closed down 2.0 percent on Friday, April 26, 2024, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Outside Day | Range Expansion | -2.00% | |
| Wide Bands | Range Expansion | -2.00% | |
| Oversold Stochastic | Weakness | -2.00% | |
| Slingshot Bearish | Bearish Swing Setup | 1.75% |
| Alert | Time |
|---|---|
| Possible NR7 | about 14 hours ago |
| Down 2 % | about 17 hours ago |
| 60 Minute Opening Range Breakdown | about 17 hours ago |
| Down 1% | about 17 hours ago |
| 10 DMA Resistance | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Medication Thyroid Eye Disease Atherosclerosis Immune Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 48.31 |
| 52 Week Low | 9.18 |
| Average Volume | 475,024 |
| 200-Day Moving Average | 27.10 |
| 50-Day Moving Average | 29.91 |
| 20-Day Moving Average | 19.01 |
| 10-Day Moving Average | 16.23 |
| Average True Range | 1.87 |
| RSI (14) | 26.47 |
| ADX | 43.48 |
| +DI | 12.75 |
| -DI | 33.76 |
| Chandelier Exit (Long, 3 ATRs) | 18.32 |
| Chandelier Exit (Short, 3 ATRs) | 20.32 |
| Upper Bollinger Bands | 25.09 |
| Lower Bollinger Band | 12.93 |
| Percent B (%b) | 0.23 |
| BandWidth | 63.94 |
| MACD Line | -4.09 |
| MACD Signal Line | -4.34 |
| MACD Histogram | 0.2528 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.80 | ||||
| Resistance 3 (R3) | 16.89 | 16.61 | 16.61 | ||
| Resistance 2 (R2) | 16.61 | 16.33 | 16.57 | 16.55 | |
| Resistance 1 (R1) | 16.15 | 16.15 | 16.01 | 16.05 | 16.49 |
| Pivot Point | 15.87 | 15.87 | 15.80 | 15.82 | 15.87 |
| Support 1 (S1) | 15.40 | 15.58 | 15.26 | 15.31 | 14.87 |
| Support 2 (S2) | 15.12 | 15.41 | 15.08 | 14.81 | |
| Support 3 (S3) | 14.66 | 15.12 | 14.75 | ||
| Support 4 (S4) | 14.56 |
